oxazoles has been researched along with Chronic Liver Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alkhouri, N; Beck, AH; Bhandari, BR; Borg, BB; Caldwell, SH; Chuang, JC; Chung, C; Ding, D; Elkhashab, M; Ghalib, R; Goodman, Z; Gunn, N; Hassanein, T; Huss, RS; Iyer, R; Jia, C; Kabler, H; Kohli, A; Kowdley, KV; Loomba, R; Myers, RP; Neff, G; Noureddin, M; Patel, K; Poulos, J; Resnick, M; Ruane, P; Sheikh, A; Shiffman, ML; Strasser, S; Subramanian, GM; Wapinski, I; Wong, VW; Younes, Z | 1 |
1 trial(s) available for oxazoles and Chronic Liver Failure
Article | Year |
---|---|
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Topics: Aged; Azetidines; Benzamides; Biomarkers; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; End Stage Liver Disease; Female; Humans; Imidazoles; Isobutyrates; Isonicotinic Acids; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxazoles; Pyridines; Pyrimidines; Severity of Illness Index; Treatment Outcome | 2021 |